AGC Biologics, a global therapeutic protein production company, announced yesterday that it has named Christopher Holt as Site Head/General Manager of its Bothell, Washington operations.
Holt will offer leadership and site management overseeing delivery of contract development and manufacturing services.
Holt has more than 20 years of leadership experience in the biotechnology and manufacturing industry, having worked for Lonza, DSM/Patheon and GlaxoSmithKline in the US and Europe.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar